Related Experiment Video
Updated: May 14, 2026
05:08
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
Structural insights on Mycobacterium tuberculosis thiazole synthase--a molecular dynamics/docking approach
1Unit of Biochemistry, Faculty of Medicine, AIMST University, Bedong, Kedah, Malaysia. rohinik23@gmail.com
Applied Biochemistry and Biotechnology
|January 24, 2013
Summary
Multi-drug resistant tuberculosis requires new drug targets. Researchers identified thiazole synthase (ThiG) as a novel target in the thiamine biosynthesis pathway, showing potential for new anti-TB drug development.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Tuberculosis (TB) remains a global epidemic, exacerbated by multi-drug resistant Mycobacterium tuberculosis.
- Novel drug targets are crucial to combat bacterial resistance and control TB.
- The thiamine biosynthesis pathway is essential for M. tuberculosis intracellular growth.
Purpose of the Study:
- To identify and characterize novel drug targets within the thiamine biosynthesis pathway of M. tuberculosis.
- To investigate thiazole synthase (ThiG) as a potential target for anti-TB drug development.
Main Methods:
- Homology modeling and molecular dynamics (MD) simulations were used to generate a 3D model of ThiG.
- Molecular docking was performed to analyze the binding of the substrate (DXP) and anti-TB drugs to ThiG.
- Key catalytic residues involved in substrate binding were identified.
Main Results:
- The homology model of ThiG predicted an (α+β)8-fold synthase fold.
- Molecular docking revealed key residues (ARG46, ASN69, THR41, LYS96) involved in substrate binding.
- Docking simulations indicated that first-line anti-TB drugs interact effectively with ThiG, potentially inhibiting the pathway.
Conclusions:
- Thiazole synthase (ThiG) is a promising novel target for anti-TB drug development.
- Inhibition of the thiamine biosynthesis pathway via ThiG could be a viable strategy to combat M. tuberculosis.
- Further research into ThiG inhibitors may lead to new treatments for drug-resistant TB.
Related Concept Videos
01:48ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
01:18ATP Synthase: Structure
ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...